EGFR and colorectal carcinoma: Chemotherapeutic agents such as 5-fluorouracil (5-FU) and oxaliplatin, as well as targeted therapies including anti-epidermal growth factor receptor (EGFR) antibodies and anti-vascular endothelial growth factor (VEGF) agents, are extensively employed in CRC treatment.